Health Canada approves new therapy Jascayd (nerandomilast) for adults with IPF and PPF, offering an option to slow lung ...

Cold and flu season can be stressful with PF, so columnist Kylene Henderson plans ahead so her family can still enjoy the ...

Columnist Ann Reynoso pays tribute to a special respiratory therapist who guided her during her pulmonary rehabilitation ...

Oral therapy admilparant slowed lung function decline in people with idiopathic pulmonary fibrosis (IPF) in a Phase 3 ...

Mobility issues have prompted columnist Sam Kirton to downsize, but he will miss the lakefront house that he and his wife called home.

Columnist Sam Kirton recalls some of the scariest moments since his IPF diagnosis, and invites readers to share their own experiences.

Taking oral dietary supplements of epigallocatechin-3-gallate (EGCG) — an antioxidant in green tea — may stop and reverse the pro-fibrotic (scarring) state of the lungs of people with idiopathic ...

The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to BMS-986278, Bristol Myers Squibb’s investigational therapy for progressive pulmonary fibrosis (PF).

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Second in a series. Read part 1 about the foundation’s work of ...